Two pharmaceutical companies took big hits in their stock

Chimerix Inc reported issues with the late stage trial of an antiviral drug and the CEO of Valeant is taking medical leave.

This entry was posted in NBR Show Clips. Bookmark the permalink.

Leave a Reply